FORNI, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.861
EU - Europa 14.900
AS - Asia 3.805
SA - Sud America 92
AF - Africa 58
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 24
Totale 40.771
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.777
GB - Regno Unito 5.849
IT - Italia 3.758
SE - Svezia 1.824
CN - Cina 1.318
DE - Germania 931
UA - Ucraina 725
TR - Turchia 724
HK - Hong Kong 689
SG - Singapore 628
FI - Finlandia 440
FR - Francia 345
BG - Bulgaria 299
RO - Romania 134
IN - India 117
RU - Federazione Russa 107
IE - Irlanda 94
BE - Belgio 77
NL - Olanda 62
CA - Canada 53
KR - Corea 51
CH - Svizzera 44
IR - Iran 41
TH - Thailandia 41
MY - Malesia 40
JP - Giappone 35
PL - Polonia 31
ES - Italia 30
VN - Vietnam 29
LT - Lituania 28
BR - Brasile 27
AU - Australia 26
ID - Indonesia 25
CZ - Repubblica Ceca 23
PT - Portogallo 23
CL - Cile 22
MX - Messico 22
EU - Europa 20
IL - Israele 17
GR - Grecia 15
TW - Taiwan 14
DZ - Algeria 13
MD - Moldavia 13
PE - Perù 12
CO - Colombia 11
EG - Egitto 11
MA - Marocco 10
AR - Argentina 9
EC - Ecuador 9
ZA - Sudafrica 9
AT - Austria 8
IQ - Iraq 8
DK - Danimarca 7
HU - Ungheria 7
PK - Pakistan 7
SN - Senegal 7
NO - Norvegia 5
NZ - Nuova Zelanda 5
BY - Bielorussia 4
BZ - Belize 4
PH - Filippine 4
RS - Serbia 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
SA - Arabia Saudita 3
YE - Yemen 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AN - Antille olandesi 2
AZ - Azerbaigian 2
CD - Congo 2
CR - Costa Rica 2
LV - Lettonia 2
MG - Madagascar 2
NG - Nigeria 2
AP - ???statistics.table.value.countryCode.AP??? 1
BN - Brunei Darussalam 1
BO - Bolivia 1
GH - Ghana 1
GL - Groenlandia 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MT - Malta 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 40.771
Salva come PNG Salva come JPEG
Città #
Southend 5.220
Fairfield 2.615
Chandler 2.171
Woodbridge 1.903
Ashburn 1.664
Jacksonville 1.613
Houston 1.282
Dearborn 1.214
Nyköping 1.060
Seattle 1.051
Ann Arbor 1.049
Wilmington 1.043
Cambridge 871
Hong Kong 675
Modena 477
Izmir 461
Beijing 440
Singapore 407
Princeton 324
Sofia 295
Eugene 275
Chicago 237
San Diego 233
Des Moines 232
Milan 214
Redwood City 180
Helsinki 179
New York 156
Rome 150
Bremen 145
Fremont 104
London 98
Boardman 88
Dublin 78
Falls Church 76
Brussels 71
Bologna 67
Shanghai 62
Naples 55
Norwalk 54
Parma 53
Hefei 52
Como 49
Florence 49
Kunming 44
Los Angeles 42
Turin 40
Napoli 39
Nanjing 36
Munich 35
Bari 31
Guangzhou 31
Tulare 31
Frankfurt am Main 30
Verona 30
Palermo 29
San Mateo 29
Jinan 26
San Giuliano Milanese 26
Ferrara 25
Indiana 25
Catania 24
Mountain View 24
Milwaukee 23
Dallas 21
Reggio Emilia 20
Auburn Hills 19
Hounslow 19
Augusta 18
Genoa 18
Hangzhou 18
Jakarta 18
Washington 18
Kocaeli 17
Perugia 17
Philadelphia 17
Toronto 17
Grafing 16
Leawood 16
Wuhan 16
Kilburn 15
Phoenix 15
Brescia 14
Hanoi 14
Saint Petersburg 14
Tokyo 14
Chisinau 13
Dong Ket 13
Istanbul 13
Nanchang 13
Ardabil 12
Brno 12
Carmichael 12
Chiswick 12
Fuzhou 12
Halifax 12
Limerick 12
Padova 12
Rende 12
Chennai 11
Totale 29.954
Salva come PNG Salva come JPEG
Nome #
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 368
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 357
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 323
Cristallinità ed equivalenza nel cloramfenicolo palmitato 295
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 290
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 288
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 277
NUTRASCIENCE s.r.l. 267
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 264
Protein corona and nanoparticles: How can we investigate on? 247
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 245
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 240
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 237
Nanoparticle transport across the blood brain barrier 232
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 232
Diffusione di derivati dell\'acido benzoico attraverso membrane lipidiche in presenza di Tween 80 232
Distribution of drugs in polymers loaded by swelling 229
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 229
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 227
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 227
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 226
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 222
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 221
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 217
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 216
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 215
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 213
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 211
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 211
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 209
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 208
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 208
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 207
Pseudomorfosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilità 201
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 200
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 199
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 198
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 197
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 197
Biodisponibilità e bioequivalenza in compresse commerciali di nitrofurantoina 196
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 195
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 194
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 193
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 192
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 191
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 189
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 189
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 188
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 187
Functionalization of liposomes: microscopical methods for preformulative screening 187
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 187
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 186
Colloidal systems for CNS drug delivery 185
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 185
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 184
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 184
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 183
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 183
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 182
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 182
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 182
Proprietà fisiche e disponibilità del cloramfenicolo palmitato in miscele macinate con cellulosa microcristallina 181
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 180
Papaverine hydrochloride release from ethyl cellulose-walled microcapsules 179
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 179
Effect of the loading method on the drug release from cross-linked carboxymethylcellulose beads 179
EFFECT OF MONTMORILLONITE ON DRUG RELEASE FROM POLYMERIC MATRICES 178
Solid state transitions and CAP availability in surface solid dispersions of chloramphenicol stearate polymorphs 178
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 178
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 177
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 176
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 176
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 176
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 175
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells 175
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 175
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 172
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 171
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 171
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 171
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 170
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 170
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 170
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 170
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process 169
Preparazione e caratterizzazione del complesso tra acido iodesossicolico e 2-idrossipropil-beta-ciclodestrina 169
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 168
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 168
Solfadiazina: microincapsulazione e studio del rilascio 167
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 167
Polymeric nanoparticles for the drug delivery to the central nervous system 165
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 165
Ketorolac tromethamine liposomes: Encapsulation and release studies 163
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 163
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 163
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 161
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 160
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 160
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 159
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 158
Totale 20.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.247
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.061 0 0 0 475 990 1.088 1.413 922 927 334 532 380
2020/20217.376 1.077 297 521 661 712 432 629 867 320 1.076 442 342
2021/20225.275 221 631 486 430 173 261 274 296 604 387 871 641
2022/20236.271 749 683 534 609 764 980 160 525 673 96 225 273
2023/20243.890 185 227 226 295 816 391 468 527 138 118 173 326
2024/20251.309 647 183 264 215 0 0 0 0 0 0 0 0
Totale 41.212